Sisu Global designs and commercializes medical devices with and for emerging markets. Sisu provides clinically proven, patented, high margin devices, starting with Hemafuse, a mechanical alternative to donor blood. With a simple push and pull of a handle Hemafuse can salvage and recycle blood from internal bleeding.can salvage and recycle blood from internal bleeding.
Hospitals in emerging markets can’t access the equipment that they need, because 80% of medical devices are designed for 10% of the world. The $91B medical device market in emerging economies is rapidly expanding, but it is fragmented. In 2014 the medical device market in Africa was $3.9B, but Frost and Sullivan predicts in will reach $16B in 2020. There is a growing middle class that is underserved for proper healthcare, facing issues like a 50% shortage of donor blood in Africa. If we could recycle a patient’s own blood in surgery, we could close this gap. Your own blood is better than someone else’s and recycling blood would also address concerns of disease burden and infrastructure.